REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Muller Pharma Slovakia, S.R.O. (Slovakia)

Main Activities: Other Miscellaneous Store Retailers
Full name: Dr. Muller Pharma Slovakia, S.R.O. Profile Updated: October 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dr. Muller Pharma Slovakia, S.R.O. is an enterprise based in Slovakia. Its main office is in Malacky. It operates in the Other Miscellaneous Store Retailers sector. It was established on January 01, 2002. It currently has a total number of 5 - 9 (2023) employees. The company’s latest financial report indicates a net sales revenue increase of 3.77% in 2023. Its’ total assets recorded a growth of 6.38%. The net profit margin of Dr. Muller Pharma Slovakia, S.R.O. decreased by 0.1% in 2023.

Headquarters
Tovarenska, 5668
Malacky; Bratislavsky; Postal Code: 90101

Contact Details: Purchase the Dr. Muller Pharma Slovakia, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Dr. Muller Pharma Slovakia, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Dr. Muller Pharma Slovakia, S.R.O. report to view the information.
Registered Capital:
Purchase the Dr. Muller Pharma Slovakia, S.R.O. report to view the information.
Incorporation Date:
January 01, 2002
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Dr. Muller Pharma Slovakia, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
3.77%
Total operating revenue
4.12%
Operating profit (EBIT)
2.46%
EBITDA
4.31%
Net Profit (Loss) for the Period
2.79%
Total assets
6.38%
Total equity
51.41%
Operating Profit Margin (ROS)
-0.17%
Net Profit Margin
-0.1%
Return on Equity (ROE)
-29.76%
Debt to Equity Ratio
-1.23%
Quick Ratio
0.49%
Cash Ratio
0.4%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?